DoctorDoctor details
Shugo Tohyama（Kanto/Tokyo）
Professor Tohyama
Fujita Health University Haneda Clinic
Professor
Regenerative Medicine Specialist
iA challenger who continues to research treatments for refractory severe heart failure using iPS cell-derived
regenerative medicine
as an alternative to heart transplants.
A pioneer paving the way for the future of regenerative medicine.
Regenerating the “Heart”
This is something that will save many lives and is Professor Tohyama’ s heartfelt mission.
Wi th h i s ye a rs of e xp e ri e n ce i n cardiology and research in regenerative medicine, he is dedicated to providing the best treatment for each and every patient.
As a cardiologist and internal medicine specialist, he brings his expertise to the health screenings at Haneda Clinic.
Professor Tohyama cares for all aspects of cardiology at Haneda Clinic, starting with
the “heart” .
- Clinical department/Main areas of expertise
- Specialized area
-
- Target Diseases
● Hypertension
● Dilated cardiomyopathy
● Hypertrophic cardiomyopathy
● Ischemic heart disease
● Secondary cardiomyopathy
● Atrial fibrillation
● Supraventricular premature beats
● Ventricular premature beats, etc
Regenerative Medicine
● Cardiomyocyte Transplantation for Ischemic Heart Disease (Clinical Trial in Progress)
● Cardiomyocyte Transplantation for Dilated Cardiomyopathy (Basic Research)
● Cardiomyocyte Transplantation for Bradyarrhythmia (Basic Research) Detail
- Target Diseases
- Qualifications/Academia/Position
-
- Doctor of Medical Science
- Cardiovascular Specialist
- General Internal Medicine Specialist｜Certified Regenerative Medicine Practitioner
- Certified Regenerative Medicine Practitioner
- Affiliated hospital
- FUJITA HEALTH UNIVERSITY HANEDA CLINIC
- location
-
〒144-0041
1-1-4, Hanedakuko, Ota-ku, Haneda Innovation City Zone A Google Map Map
- Biography
-
- 2006
- Graduated from Keio University School of Medicine
- 2006
- Resident Physician, Saiseikai Central Hospital, Tokyo
- 2013
- PhD in Medicine, Graduate School of Medical Sciences, Keio University (Major in Internal Medicine)
- 2013
- JSPS Research Fellow (PD)
- 2018
- Principal Investigator, AMED Research Center Network for Realization of Regenerative Medicine (3 years)
- 2020
- Assistant Professor, Department of Cardiology, Keio University School of Medicine
- 2022
- Principal Investigator, AMED Acceleration Program of R&D and Implementation for Regenerative Medicine and Cell and Gene Therapy (3 years)
- 2023
- Principal Investigator, Kanagawa Institute of Industrial Science and Technology (KISTEC) (2 years)
- 2024
- Principal Investigator, AMED Acceleration Program of R&D and Implementation for Regenerative Medicine and Cell and Gene Therapy (3 years)
- 2024
- Associate Professor, Fujita Medical Innovation Center Tokyo Professor, Fujita Medical Innovation Center Tokyo
- paper
-
- 1. Kobayashi H, Tohyama S, et al. Regeneration of Nonhuman Primate Hearts With Human Induced Pluripotent Stem Cell-Derived Cardiac Spheroids. Circulation 2024
- 2. Moriwaki T, Tohyama S, et al. Scalable production of homogeneous cardiac organoids derived from human pluripotent stem cells. Cell Reports Methods 3(12) 100666 2023
- 3. Kurashina Y, Tohyama S, et al. Hydrogel-Sheathed HiPSC-Derived Heart Microtissue Enables Anchor-Free Contractile Force Measurement. Advanced Science e2301831 2023
- 4. Tani H, Tohyama S, et al. Heart-derived collagen promotes maturation of engineered heart tissue. Biomaterials 299 122174-122174 2023
- 5. Tanosaki S, Tohyama S, et al. Fatty Acid Synthesis Is Indispensable for Survival of Human Pluripotent Stem Cells. iScience 23(9) 101535-101535 2020
- 6. Tohyama S, et al. Glutamine Oxidation Is Indispensable for Survival of Human Pluripotent Stem Cells. Cell Metabolism 23(4) 663-74 2016
- 7. Tohyama S, et al. Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. Cell Stem Cell 12(1) 127-37 2013
- others
- ■Main Research
I have been dedicated to advancing cardiac regenerative medicine and drug discovery research using human iPS cells, along with investigating the underlying mechanisms of diseases for many years.
■Awards
2023 : Kitasato Award (Keio University School of Medicine)
2022 : Jokichi Takamine Young Investigator Award (The Society of Cardiovascular Endocrinology and Metabolism)
2021 : Japanese Heart Failure Society Outstanding Investigator Award
2019 : Medical Research Encouragement Prize of The Japan Medical Association
2019 : Japan Medical Congress Encouragement Award
2018 : Okamoto Research Encouragement Award (The Japan Research Foundation for Healthy Aging)
2018 : Young Scientist Award by the Minister of Education, Culture, Sports, Science and Technology
2017 : Cardiovascular Regenerative Medicine Award (The Japanese Circulation Society)
2013 : Ikushi Prize (Japan Society for the Promotion of Science)
2011 : Young Investigator's Award (The Japanese Society for Regenerative Medicine)
This doctor's treatment program
-
Inquiry about Second Opinion Program for Surgery by Dr. Tohyama (Fujita Health University Haneda Clinic)
Internal medicineCardiovascular Specialist General Internal Medicine Specialist Certified Regenerative Medicine PractitionerFUJITA HEALTH UNIVERSITY HANEDA CLINIC（Kanto/Tokyo）
Inquiry about Second Opinion Program for Surgery by Dr. Tohyama (Fujita Health University Haneda Clinic)
See details